Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongxin Cao

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Current Molecular Medicine|June 20, 2019
Role of Polymorphisms of FAM13A, PHLDB1, and CYP24A1 in Breast Cancer RiskYing Wei, Xiaolin Wang, Zhe Zhang, et al.
Planta Medica|October 28, 2010
Clinical studies with traditional Chinese medicine in the past decade and future research and developmentMiao Jiang, Jing Yang, Chi Zhang, et al.
Medicine|April 29, 2016
The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort StudiesLinhai Zhu, Hongxin Cao, Tiehong Zhang, et al.
American Journal of Cancer Research|August 10, 2023
Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancerXiang Li, Jinlong Ma, Zhenqian Sun, et al.
Frontiers in Genetics|October 13, 2022
Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancerXiang Li, Zihan Dai, Jincheng Liu, et al.
Plos One|August 20, 2015
Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung CancerHongxin Cao, Wei Dong, Hongchang Shen, et al.
Medical Oncology (Northwood, London, England)|August 8, 2014
Forced vital capacity predicts long-term survival for curative-resected NSCLCXi Guo, Hongxin Cao, Jun Xu, et al.
Plos One|February 5, 2026
Model of leaf biomass partitioning coefficient in different main stem leaf ranks of rapeseed (Brassica napus L.)Weixin Zhang, Wenyu Zhang, Qian Wu, et al.
Scientific Reports|August 5, 2016
Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLCHongxin Cao, Wei Dong, Xiao Qu, et al.
Journal of Ethnopharmacology|February 27, 2010
Pharmacokinetics-based elucidation on disparity in clinical effectiveness between varieties of Zhi Zhu Wan, a Traditional Chinese Medical formulaHongxin Cao, Xi Chen, Hui Sun, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Current Molecular Medicine|June 20, 2019
Role of Polymorphisms of FAM13A, PHLDB1, and CYP24A1 in Breast Cancer RiskYing Wei, Xiaolin Wang, Zhe Zhang, et al.
Planta Medica|October 28, 2010
Clinical studies with traditional Chinese medicine in the past decade and future research and developmentMiao Jiang, Jing Yang, Chi Zhang, et al.
Medicine|April 29, 2016
The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort StudiesLinhai Zhu, Hongxin Cao, Tiehong Zhang, et al.
American Journal of Cancer Research|August 10, 2023
Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancerXiang Li, Jinlong Ma, Zhenqian Sun, et al.
Frontiers in Genetics|October 13, 2022
Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancerXiang Li, Zihan Dai, Jincheng Liu, et al.
Plos One|August 20, 2015
Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung CancerHongxin Cao, Wei Dong, Hongchang Shen, et al.
Medical Oncology (Northwood, London, England)|August 8, 2014
Forced vital capacity predicts long-term survival for curative-resected NSCLCXi Guo, Hongxin Cao, Jun Xu, et al.
Plos One|February 5, 2026
Model of leaf biomass partitioning coefficient in different main stem leaf ranks of rapeseed (Brassica napus L.)Weixin Zhang, Wenyu Zhang, Qian Wu, et al.
Scientific Reports|August 5, 2016
Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLCHongxin Cao, Wei Dong, Xiao Qu, et al.
Journal of Ethnopharmacology|February 27, 2010
Pharmacokinetics-based elucidation on disparity in clinical effectiveness between varieties of Zhi Zhu Wan, a Traditional Chinese Medical formulaHongxin Cao, Xi Chen, Hui Sun, et al.
Pageof 7